Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2+ breast cancer cells on biomarkers of monocyte antitumor activity
Dahmani Z., Addou-Klouche L, Gizard F., Dahou S, Messaoud A, Chahinez Djebri N, Benaissti M.I, Mostefaoui M, Terbeche H, Nouari W, Miliani M, Lefranc . , Fernandez A, Lamb N J. and Aribi M.
PRDM9 activity depends on HELLS and promotes local 5-hydroxymethylcytosine enrichment.
Akerman I, Kasaai B, Bazarova A, Sang PB, Peiffer I, Artufel M, Derelle R, Smith G, Rodriguez-Martinez M, Romano M, Kinet S, Tino P, Theillet C, Taylor N, Ballester B, Méchali M
Tantale K., Garcia-Oliver, E., L’Hostis, A., Yang, Y., Robert, MC., Gostan, T., Basu, M., Kozulic-Pirher, A., Andrau, JC., Muller, F., Basyuk, E., Radulescu, O., E. Bertrand
Promonet A, Padioleau I, Liu Y, Sanz L, Biernacka A, Schmitz AL, Skrzypczak M, Sarrazin A, Mettling C, Rowicka M, Ginalski K, Chedin F, Chen CL, Lin YL, Pasero P